NCT03790007

Brief Summary

Since 1987, laparoscopic cholecystectomy has become the standard procedure for gallbladder stones and lesions. Complications due to improvements in laparoscopy and increased surgical experience have decreased day by day, but there is still a problem in terms of postoperative pain management. Several pain management procedures have been tried to combat pain after laparoscopic cholecystectomy. The aim of this study is to decrease the length of hospital stay, to increase the comfort of the patient and to reduce the cost of treatment. Local anesthetic injection to port locations, intraperitoneal periportal local anesthetic injection ,Transversus Abdominis Plane Blok and without any local anesthetic application to the control group compared to the group's analgesic efficiency and to reduce the amount of analgesics needed, shorten the length of hospital stay and improve patient comfort.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for phase_4 postoperative-pain

Timeline
Completed

Started Nov 2018

Typical duration for phase_4 postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 15, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 31, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

March 23, 2021

Status Verified

March 1, 2021

Enrollment Period

2.1 years

First QC Date

December 15, 2018

Last Update Submit

March 19, 2021

Conditions

Keywords

laparoscopic cholecystectomypostoperative pain relieflocal anesthetic

Outcome Measures

Primary Outcomes (1)

  • Level of postoperative pain: visual analogue scale

    the level of the pain will be assessed using the VAS ( visual analogue scale) which is a psychometric response scale and the patient has to indicate a position along a continuous line between two end-points (no pain and maximum pain) that best reflects the intensity of their pain. The pain measurements will be done at 1,2,4,6,12,24 hours. Test is easy to obtain, reliable, valid and can detect changes of over time

    24 hours

Study Arms (4)

Transversus Abdominis Plane Block

ACTIVE COMPARATOR

Transversus abdominis plane block (10 cc / 10 cc, 0.5% bupivacaine to the right and left transversus abdominis muscle regions) will be applied.

Drug: Bupivacaine

TROCHAR SITES LOCAL ANESTHETIC INJECTION

ACTIVE COMPARATOR

local anesthetic injection (6 cc to subxiphoid and infraumbilical trocar sites, 4 cc instead of 2 cc, 0.5% bupivacaine solution to be applied)

Drug: Bupivacaine

INTRAPERİTONEAL LOCAL ANESTHETIC SPREADING METHOD

ACTIVE COMPARATOR

Intraperitoneal direct vision of the gallbladder excision area-periportal area under the direct injection of local anesthetic spraying process (percutaneous method injected into the periportal area 1: 1 diluted with 20 cc SF, 20 cc 0.5% bupivacaine solution total 40 cc spraying will be applied.

Drug: Bupivacaine

CONTROL GROUP

NO INTERVENTION

group will be the control group and any of these methods will not be applied,

Interventions

In our study this local anesthetic agent will be applied for postoperative pain relief

Also known as: marcaine
INTRAPERİTONEAL LOCAL ANESTHETIC SPREADING METHODTROCHAR SITES LOCAL ANESTHETIC INJECTIONTransversus Abdominis Plane Block

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age who were admitted to the general surgery department with the diagnosis of cholelithiasis

You may not qualify if:

  • Patients who need to undergo peroperative open cholecystectomy procedure.
  • Patients with local anesthetic or NSAID allergy
  • Patients in pregnancy
  • Patients who are breastfeeding
  • Patients with connective tissue disease
  • Patients with malignancy in postoperative gallbladder pathological examination and patients with any malignancy diagnosis
  • Patients with renal impairment, where the effect of using Marcain is unknown
  • Cardiac disease
  • Patients with hepatic impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatih Sultan Mehmet Research and Training Hospital

Istanbul, 34734, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: 3 types of local anesthetic applying method will be compared
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
asistant doctor

Study Record Dates

First Submitted

December 15, 2018

First Posted

December 31, 2018

Study Start

November 1, 2018

Primary Completion

December 1, 2020

Study Completion

March 1, 2021

Last Updated

March 23, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations